1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Post Herpetic Neuralgia Therapies Revenue 1.4 Market Analysis by Type 1.4.1 Global Post Herpetic Neuralgia Therapies Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Drugs 1.4.3 Patches 1.4.4 Steroid Injectable 1.5 Market by Application 1.5.1 Global Post Herpetic Neuralgia Therapies Market Share by Application: 2020 VS 2026 1.5.2 Hospital Pharmacies 1.5.3 Online Pharmacies 1.5.4 Retail Pharmacies 1.6 Coronavirus Disease 2019 (Covid-19): Post Herpetic Neuralgia Therapies Industry Impact 1.6.1 How the Covid-19 is Affecting the Post Herpetic Neuralgia Therapies Industry 1.6.1.1 Post Herpetic Neuralgia Therapies Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Post Herpetic Neuralgia Therapies Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Post Herpetic Neuralgia Therapies Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Post Herpetic Neuralgia Therapies Market Perspective (2015-2026) 2.2 Post Herpetic Neuralgia Therapies Growth Trends by Regions 2.2.1 Post Herpetic Neuralgia Therapies Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Post Herpetic Neuralgia Therapies Historic Market Share by Regions (2015-2020) 2.2.3 Post Herpetic Neuralgia Therapies Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Post Herpetic Neuralgia Therapies Market Growth Strategy 2.3.6 Primary Interviews with Key Post Herpetic Neuralgia Therapies Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Post Herpetic Neuralgia Therapies Players by Market Size 3.1.1 Global Top Post Herpetic Neuralgia Therapies Players by Revenue (2015-2020) 3.1.2 Global Post Herpetic Neuralgia Therapies Revenue Market Share by Players (2015-2020) 3.1.3 Global Post Herpetic Neuralgia Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Post Herpetic Neuralgia Therapies Market Concentration Ratio 3.2.1 Global Post Herpetic Neuralgia Therapies Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Post Herpetic Neuralgia Therapies Revenue in 2019 3.3 Post Herpetic Neuralgia Therapies Key Players Head office and Area Served 3.4 Key Players Post Herpetic Neuralgia Therapies Product Solution and Service 3.5 Date of Enter into Post Herpetic Neuralgia Therapies Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Post Herpetic Neuralgia Therapies Historic Market Size by Type (2015-2020) 4.2 Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Type (2021-2026) 5 Post Herpetic Neuralgia Therapies Breakdown Data by Application (2015-2026) 5.1 Global Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) 5.2 Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Post Herpetic Neuralgia Therapies Market Size (2015-2020) 6.2 Post Herpetic Neuralgia Therapies Key Players in North America (2019-2020) 6.3 North America Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) 6.4 North America Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) 7 Europe 7.1 Europe Post Herpetic Neuralgia Therapies Market Size (2015-2020) 7.2 Post Herpetic Neuralgia Therapies Key Players in Europe (2019-2020) 7.3 Europe Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) 7.4 Europe Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) 8 China 8.1 China Post Herpetic Neuralgia Therapies Market Size (2015-2020) 8.2 Post Herpetic Neuralgia Therapies Key Players in China (2019-2020) 8.3 China Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) 8.4 China Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) 9 Japan 9.1 Japan Post Herpetic Neuralgia Therapies Market Size (2015-2020) 9.2 Post Herpetic Neuralgia Therapies Key Players in Japan (2019-2020) 9.3 Japan Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) 9.4 Japan Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Post Herpetic Neuralgia Therapies Market Size (2015-2020) 10.2 Post Herpetic Neuralgia Therapies Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) 10.4 Southeast Asia Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) 11 India 11.1 India Post Herpetic Neuralgia Therapies Market Size (2015-2020) 11.2 Post Herpetic Neuralgia Therapies Key Players in India (2019-2020) 11.3 India Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) 11.4 India Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Post Herpetic Neuralgia Therapies Market Size (2015-2020) 12.2 Post Herpetic Neuralgia Therapies Key Players in Central & South America (2019-2020) 12.3 Central & South America Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) 12.4 Central & South America Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Endo Pharmaceuticals 13.1.1 Endo Pharmaceuticals Company Details 13.1.2 Endo Pharmaceuticals Business Overview and Its Total Revenue 13.1.3 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Introduction 13.1.4 Endo Pharmaceuticals Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020)) 13.1.5 Endo Pharmaceuticals Recent Development 13.2 Depomed 13.2.1 Depomed Company Details 13.2.2 Depomed Business Overview and Its Total Revenue 13.2.3 Depomed Post Herpetic Neuralgia Therapies Introduction 13.2.4 Depomed Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) 13.2.5 Depomed Recent Development 13.3 Acorda Therapeutics 13.3.1 Acorda Therapeutics Company Details 13.3.2 Acorda Therapeutics Business Overview and Its Total Revenue 13.3.3 Acorda Therapeutics Post Herpetic Neuralgia Therapies Introduction 13.3.4 Acorda Therapeutics Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) 13.3.5 Acorda Therapeutics Recent Development 13.4 Pfizer 13.4.1 Pfizer Company Details 13.4.2 Pfizer Business Overview and Its Total Revenue 13.4.3 Pfizer Post Herpetic Neuralgia Therapies Introduction 13.4.4 Pfizer Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) 13.4.5 Pfizer Recent Development 13.5 Mylan 13.5.1 Mylan Company Details 13.5.2 Mylan Business Overview and Its Total Revenue 13.5.3 Mylan Post Herpetic Neuralgia Therapies Introduction 13.5.4 Mylan Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) 13.5.5 Mylan Recent Development 13.6 Daiichi Sankyo 13.6.1 Daiichi Sankyo Company Details 13.6.2 Daiichi Sankyo Business Overview and Its Total Revenue 13.6.3 Daiichi Sankyo Post Herpetic Neuralgia Therapies Introduction 13.6.4 Daiichi Sankyo Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) 13.6.5 Daiichi Sankyo Recent Development 13.7 Teikoku Pharma 13.7.1 Teikoku Pharma Company Details 13.7.2 Teikoku Pharma Business Overview and Its Total Revenue 13.7.3 Teikoku Pharma Post Herpetic Neuralgia Therapies Introduction 13.7.4 Teikoku Pharma Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) 13.7.5 Teikoku Pharma Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Post Herpetic Neuralgia Therapies Key Market Segments Table 2. Key Players Covered: Ranking by Post Herpetic Neuralgia Therapies Revenue Table 3. Ranking of Global Top Post Herpetic Neuralgia Therapies Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Post Herpetic Neuralgia Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Drugs Table 6. Key Players of Patches Table 7. Key Players of Steroid Injectable Table 8. COVID-19 Impact Global Market: (Four Post Herpetic Neuralgia Therapies Market Size Forecast Scenarios) Table 9. Opportunities and Trends for Post Herpetic Neuralgia Therapies Players in the COVID-19 Landscape Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 11. Key Regions/Countries Measures against Covid-19 Impact Table 12. Proposal for Post Herpetic Neuralgia Therapies Players to Combat Covid-19 Impact Table 13. Global Post Herpetic Neuralgia Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 14. Global Post Herpetic Neuralgia Therapies Market Size by Regions (US$ Million): 2020 VS 2026 Table 15. Global Post Herpetic Neuralgia Therapies Market Size by Regions (2015-2020) (US$ Million) Table 16. Global Post Herpetic Neuralgia Therapies Market Share by Regions (2015-2020) Table 17. Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 18. Global Post Herpetic Neuralgia Therapies Market Share by Regions (2021-2026) Table 19. Market Top Trends Table 20. Key Drivers: Impact Analysis Table 21. Key Challenges Table 22. Post Herpetic Neuralgia Therapies Market Growth Strategy Table 23. Main Points Interviewed from Key Post Herpetic Neuralgia Therapies Players Table 24. Global Post Herpetic Neuralgia Therapies Revenue by Players (2015-2020) (Million US$) Table 25. Global Post Herpetic Neuralgia Therapies Market Share by Players (2015-2020) Table 26. Global Top Post Herpetic Neuralgia Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Post Herpetic Neuralgia Therapies as of 2019) Table 27. Global Post Herpetic Neuralgia Therapies by Players Market Concentration Ratio (CR5 and HHI) Table 28. Key Players Headquarters and Area Served Table 29. Key Players Post Herpetic Neuralgia Therapies Product Solution and Service Table 30. Date of Enter into Post Herpetic Neuralgia Therapies Market Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$) Table 33. Global Post Herpetic Neuralgia Therapies Market Size Share by Type (2015-2020) Table 34. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Type (2021-2026) Table 35. Global Post Herpetic Neuralgia Therapies Market Size Share by Application (2015-2020) Table 36. Global Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$) Table 37. Global Post Herpetic Neuralgia Therapies Market Size Share by Application (2021-2026) Table 38. North America Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$) Table 39. North America Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020) Table 40. North America Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$) Table 41. North America Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020) Table 42. North America Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$) Table 43. North America Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020) Table 44. Europe Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$) Table 45. Europe Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020) Table 46. Europe Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$) Table 47. Europe Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020) Table 48. Europe Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$) Table 49. Europe Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020) Table 50. China Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$) Table 51. China Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020) Table 52. China Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$) Table 53. China Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020) Table 54. China Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$) Table 55. China Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020) Table 56. Japan Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$) Table 57. Japan Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020) Table 58. Japan Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$) Table 59. Japan Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020) Table 60. Japan Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$) Table 61. Japan Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020) Table 62. Southeast Asia Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$) Table 63. Southeast Asia Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020) Table 64. Southeast Asia Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$) Table 65. Southeast Asia Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020) Table 66. Southeast Asia Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$) Table 67. Southeast Asia Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020) Table 68. India Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$) Table 69. India Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020) Table 70. India Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$) Table 71. India Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020) Table 72. India Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$) Table 73. India Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020) Table 74. Central & South America Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$) Table 75. Central & South America Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020) Table 76. Central & South America Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$) Table 77. Central & South America Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020) Table 78. Central & South America Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$) Table 79. Central & South America Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020) Table 80. Endo Pharmaceuticals Company Details Table 81. Endo Pharmaceuticals Business Overview Table 82. Endo Pharmaceuticals Product Table 83. Endo Pharmaceuticals Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$) Table 84. Endo Pharmaceuticals Recent Development Table 85. Depomed Company Details Table 86. Depomed Business Overview Table 87. Depomed Product Table 88. Depomed Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$) Table 89. Depomed Recent Development Table 90. Acorda Therapeutics Company Details Table 91. Acorda Therapeutics Business Overview Table 92. Acorda Therapeutics Product Table 93. Acorda Therapeutics Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$) Table 94. Acorda Therapeutics Recent Development Table 95. Pfizer Company Details Table 96. Pfizer Business Overview Table 97. Pfizer Product Table 98. Pfizer Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$) Table 99. Pfizer Recent Development Table 100. Mylan Company Details Table 101. Mylan Business Overview Table 102. Mylan Product Table 103. Mylan Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$) Table 104. Mylan Recent Development Table 105. Daiichi Sankyo Company Details Table 106. Daiichi Sankyo Business Overview Table 107. Daiichi Sankyo Product Table 108. Daiichi Sankyo Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$) Table 109. Daiichi Sankyo Recent Development Table 110. Teikoku Pharma Company Details Table 111. Teikoku Pharma Business Overview Table 112. Teikoku Pharma Product Table 113. Teikoku Pharma Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$) Table 114. Teikoku Pharma Recent Development Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Global Post Herpetic Neuralgia Therapies Market Share by Type: 2020 VS 2026 Figure 2. Drugs Features Figure 3. Patches Features Figure 4. Steroid Injectable Features Figure 5. Global Post Herpetic Neuralgia Therapies Market Share by Application: 2020 VS 2026 Figure 6. Hospital Pharmacies Case Studies Figure 7. Online Pharmacies Case Studies Figure 8. Retail Pharmacies Case Studies Figure 9. Post Herpetic Neuralgia Therapies Report Years Considered Figure 10. Global Post Herpetic Neuralgia Therapies Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Post Herpetic Neuralgia Therapies Market Share by Regions: 2020 VS 2026 Figure 12. Global Post Herpetic Neuralgia Therapies Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Post Herpetic Neuralgia Therapies Market Share by Players in 2019 Figure 15. Global Top Post Herpetic Neuralgia Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Post Herpetic Neuralgia Therapies as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Post Herpetic Neuralgia Therapies Revenue in 2019 Figure 17. North America Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Endo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Endo Pharmaceuticals Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020) Figure 26. Depomed Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Depomed Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020) Figure 28. Acorda Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Acorda Therapeutics Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020) Figure 30. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Pfizer Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020) Figure 32. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Mylan Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020) Figure 34. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Daiichi Sankyo Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020) Figure 36. Teikoku Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Teikoku Pharma Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020) Figure 38. Bottom-up and Top-down Approaches for This Report Figure 39. Data Triangulation Figure 40. Key Executives Interviewed

Endo Pharmaceuticals Depomed Acorda Therapeutics Pfizer Mylan Daiichi Sankyo Teikoku Pharma